US 9121852
Carcinoma diagnosis and treatment, based on ODC1 genotype
granted A61KA61K31/192A61K31/198
Quick answer
US patent 9121852 (Carcinoma diagnosis and treatment, based on ODC1 genotype) held by THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION
- Grant date
- Tue Sep 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K31/192, A61K31/198, A61K31/415, A61P